Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies

Sarah E McNeil, Anil Vangala, Vincent W Bramwell, Peter J Hanson, Yvonne Perrie

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The aim of these studies was to compare the effect of liposome composition on physico-chemical characteristics and transfection efficacy of cationic liposomes both in vitro and in vivo. Comparison between 4 popularly used cationic lipids, showed 3b-N-(dimethylaminoethyl)carbamate (DC-Chol) to promote the highest transfect levels in cells in vitro with levels being at least 6 times higher than those of 1,2-di-O-octadecenyl-3-trimethylammonium propane (DOTMA). 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), and dimethyldioctadecylammonium (DDA) and approximately twice as efficient as dipalmitoyl-trimethylammonium-propane (DPTAP). To establish the role of the helper lipid, DC-Chol liposomes were formulated in combination with either 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE) or cholesterol (Chol) (1:1 molar ratio) with and without the addition of phosphatidyl choline. The choice of helper lipid incorporated within the bilayer was found to influence the formation of complexes, their resultant structure and their transfection efficiency in vitro, with SUV-DNA complexes containing optimum levels of DOPE giving higher transfection than those containing cholesterol. The inclusion of PC within the formulation also reduced transfection efficiency in vitro. However, when administered in vivo, SUV-DNA complexes composed of PC:Chol:DC-Chol at a molar ratio of 16:8:4 micromole/ml were the most effective at inducing splenocyte proliferation upon exposure to antigen in comparison to control spleens. These results demonstrate that there is no in vitro/in vivo correlation between the transfection efficacy of these liposome formulations and in vitro transfection in the above cell model cannot be taken as a reliable indicator for in vivo efficacy of DNA vaccines.

LanguageEnglish
Pages175-187
Number of pages13
JournalCurrent Drug Delivery
Volume7
Issue number2
DOIs
Publication statusPublished - 30 Apr 2010

Fingerprint

Transfection
Vaccination
Cholesterol
Liposomes
Propane
Lipids
DNA Vaccines
Carbamates
DNA
Phosphatidylcholines
In Vitro Techniques
Spleen
Antigens
phosphatidylethanolamine

Keywords

  • drug delivery systems
  • COS cells
  • cell proliferation
  • cercopithecus aethiops
  • chemistry, pharmaceutical
  • cytokines

Cite this

McNeil, Sarah E ; Vangala, Anil ; Bramwell, Vincent W ; Hanson, Peter J ; Perrie, Yvonne. / Lipoplexes formulation and optimisation : in vitro transfection studies reveal no correlation with in vivo vaccination studies. In: Current Drug Delivery. 2010 ; Vol. 7, No. 2. pp. 175-187.
@article{658470b365f84926ab9a351410603451,
title = "Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies",
abstract = "The aim of these studies was to compare the effect of liposome composition on physico-chemical characteristics and transfection efficacy of cationic liposomes both in vitro and in vivo. Comparison between 4 popularly used cationic lipids, showed 3b-N-(dimethylaminoethyl)carbamate (DC-Chol) to promote the highest transfect levels in cells in vitro with levels being at least 6 times higher than those of 1,2-di-O-octadecenyl-3-trimethylammonium propane (DOTMA). 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), and dimethyldioctadecylammonium (DDA) and approximately twice as efficient as dipalmitoyl-trimethylammonium-propane (DPTAP). To establish the role of the helper lipid, DC-Chol liposomes were formulated in combination with either 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE) or cholesterol (Chol) (1:1 molar ratio) with and without the addition of phosphatidyl choline. The choice of helper lipid incorporated within the bilayer was found to influence the formation of complexes, their resultant structure and their transfection efficiency in vitro, with SUV-DNA complexes containing optimum levels of DOPE giving higher transfection than those containing cholesterol. The inclusion of PC within the formulation also reduced transfection efficiency in vitro. However, when administered in vivo, SUV-DNA complexes composed of PC:Chol:DC-Chol at a molar ratio of 16:8:4 micromole/ml were the most effective at inducing splenocyte proliferation upon exposure to antigen in comparison to control spleens. These results demonstrate that there is no in vitro/in vivo correlation between the transfection efficacy of these liposome formulations and in vitro transfection in the above cell model cannot be taken as a reliable indicator for in vivo efficacy of DNA vaccines.",
keywords = "drug delivery systems, COS cells, cell proliferation, cercopithecus aethiops, chemistry, pharmaceutical, cytokines",
author = "McNeil, {Sarah E} and Anil Vangala and Bramwell, {Vincent W} and Hanson, {Peter J} and Yvonne Perrie",
year = "2010",
month = "4",
day = "30",
doi = "10.2174/156720110791011774",
language = "English",
volume = "7",
pages = "175--187",
journal = "Current Drug Delivery",
issn = "1567-2018",
number = "2",

}

Lipoplexes formulation and optimisation : in vitro transfection studies reveal no correlation with in vivo vaccination studies. / McNeil, Sarah E; Vangala, Anil; Bramwell, Vincent W; Hanson, Peter J; Perrie, Yvonne.

In: Current Drug Delivery, Vol. 7, No. 2, 30.04.2010, p. 175-187.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lipoplexes formulation and optimisation

T2 - Current Drug Delivery

AU - McNeil, Sarah E

AU - Vangala, Anil

AU - Bramwell, Vincent W

AU - Hanson, Peter J

AU - Perrie, Yvonne

PY - 2010/4/30

Y1 - 2010/4/30

N2 - The aim of these studies was to compare the effect of liposome composition on physico-chemical characteristics and transfection efficacy of cationic liposomes both in vitro and in vivo. Comparison between 4 popularly used cationic lipids, showed 3b-N-(dimethylaminoethyl)carbamate (DC-Chol) to promote the highest transfect levels in cells in vitro with levels being at least 6 times higher than those of 1,2-di-O-octadecenyl-3-trimethylammonium propane (DOTMA). 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), and dimethyldioctadecylammonium (DDA) and approximately twice as efficient as dipalmitoyl-trimethylammonium-propane (DPTAP). To establish the role of the helper lipid, DC-Chol liposomes were formulated in combination with either 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE) or cholesterol (Chol) (1:1 molar ratio) with and without the addition of phosphatidyl choline. The choice of helper lipid incorporated within the bilayer was found to influence the formation of complexes, their resultant structure and their transfection efficiency in vitro, with SUV-DNA complexes containing optimum levels of DOPE giving higher transfection than those containing cholesterol. The inclusion of PC within the formulation also reduced transfection efficiency in vitro. However, when administered in vivo, SUV-DNA complexes composed of PC:Chol:DC-Chol at a molar ratio of 16:8:4 micromole/ml were the most effective at inducing splenocyte proliferation upon exposure to antigen in comparison to control spleens. These results demonstrate that there is no in vitro/in vivo correlation between the transfection efficacy of these liposome formulations and in vitro transfection in the above cell model cannot be taken as a reliable indicator for in vivo efficacy of DNA vaccines.

AB - The aim of these studies was to compare the effect of liposome composition on physico-chemical characteristics and transfection efficacy of cationic liposomes both in vitro and in vivo. Comparison between 4 popularly used cationic lipids, showed 3b-N-(dimethylaminoethyl)carbamate (DC-Chol) to promote the highest transfect levels in cells in vitro with levels being at least 6 times higher than those of 1,2-di-O-octadecenyl-3-trimethylammonium propane (DOTMA). 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), and dimethyldioctadecylammonium (DDA) and approximately twice as efficient as dipalmitoyl-trimethylammonium-propane (DPTAP). To establish the role of the helper lipid, DC-Chol liposomes were formulated in combination with either 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE) or cholesterol (Chol) (1:1 molar ratio) with and without the addition of phosphatidyl choline. The choice of helper lipid incorporated within the bilayer was found to influence the formation of complexes, their resultant structure and their transfection efficiency in vitro, with SUV-DNA complexes containing optimum levels of DOPE giving higher transfection than those containing cholesterol. The inclusion of PC within the formulation also reduced transfection efficiency in vitro. However, when administered in vivo, SUV-DNA complexes composed of PC:Chol:DC-Chol at a molar ratio of 16:8:4 micromole/ml were the most effective at inducing splenocyte proliferation upon exposure to antigen in comparison to control spleens. These results demonstrate that there is no in vitro/in vivo correlation between the transfection efficacy of these liposome formulations and in vitro transfection in the above cell model cannot be taken as a reliable indicator for in vivo efficacy of DNA vaccines.

KW - drug delivery systems

KW - COS cells

KW - cell proliferation

KW - cercopithecus aethiops

KW - chemistry, pharmaceutical

KW - cytokines

UR - http://www.ingentaconnect.com/contentone/ben/cdd/2010/00000007/00000002/art00010

U2 - 10.2174/156720110791011774

DO - 10.2174/156720110791011774

M3 - Article

VL - 7

SP - 175

EP - 187

JO - Current Drug Delivery

JF - Current Drug Delivery

SN - 1567-2018

IS - 2

ER -